Benjamin W. Stango

Ben specializes in a wide array of finance matters, including syndicated credits with institutional lenders, leveraged acquisition and asset-based financings, account receivables facilities, and senior and mezzanine venture financings. His clients span across an array of industries, from retail to healthcare, with transaction sizes ranging from under $1 million to more than $3 billion. With an MBA from The Wharton School, Ben brings a unique perspective on business and law to serve his clients’ needs.

At the firm, Ben serves on the Philadelphia Associates Committee; the Environmental, Social, and Governance Working Group; and the Philadelphia Professional Recruiting Committee. He previously served on the Global Associates Committee, advising the Firm Chair and leadership team on associate matters.

Ben remains heavily engaged in Philadelphia’s civic community. He currently serves on the board of directors for the Support Center for Child Advocates, where he volunteers as a Child Advocate pro bono attorney, and serves as the co-chair of the Philadelphia Bar Association’s Large Firm Associates Committee. Ben is also an advisor to numerous civic and political organizations throughout Philadelphia.

Notable Public Company Representations

• Cencora, Inc. (NYSE: COR), one of the largest global pharmaceutical sourcing and distribution services companies, in connection with general treasury matters:
  • Its $2.5 billion senior multicurrency cross-border revolving credit facility
  • Term loan and senior note financings for its $6.275 billion acquisition of Alliance Healthcare from Walgreens Boots Alliance
  • A global reorganization involving legal entities in multiple countries including the United Kingdom, Singapore, Australia, Switzerland, and Luxembourg
  • Finance matters related to its $1.29 billion acquisition of PharmaLex, a provider of specialized services for the pharma, biotech, and medtech industries, from funds advised by AUCTUS Capital Partners AG
  • The company’s global rebranding from “AmerisourceBergen Corporation” to “Cencora, Inc”
  • Its entry into a $2.4 billion commercial paper program
  • More than $5 billion in senior note offerings and other financings since 2017
• Arcadium
  • $500 million senior secured revolving credit facility
• Livent Corporation (NYSE: LTHM), a leading, global, fully integrated lithium company and formerly the lithium business of FMC Corporation, in connection with:
  • $500 million senior secured revolving credit facility
  • $225 million of convertible senior “green” notes due 2025
  • $252.4 million follow-on common stock offering
• FMC Corporation (NYSE: FMC), a global agricultural sciences company, in connection with general treasury matters and
  • Its $2 billion senior revolving credit facility
  • More than $1 billion in senior note offerings since 2017
• CompoSecure Inc (NASDAQ: CMPO) regarding its credit facility with JPMorgan Chase and the issuance of certain senior notes
• Axon Enterprise, Inc. (NASDAQ: AXON) in connection with its credit facility with JPMorgan Chase
• ADMA Biologics (NASDAQ: ADMA) in connection with its 2022 debt refinancing and 2023 asset-based credit facility with Ares Capital

Notable Private Equity Representations

• Sun Capital Partners in connection with numerous acquisition financings
• LLR Partners in connection with numerous acquisition financings
• Walnut Grove Capital Partners in connection with numerous acquisition financings

Other Notable Representations

• A national health insurance company in connection with its $300 million credit facility and general treasury matters
• Reinvestment Fund, a nonprofit organization and community development financial institution, in connection with numerous loans to fund its mission-driven investments
• A banking executive in his personal capacity in a material amendment and renegotiation of two large, personal, private banking loans with his existing lender
• PAE Inc. in connection with a $740 million senior secured term loan facility and a $175 million senior secured asset-based revolving credit facility
• A national nonprofit organization that collects, stores, and distributes biological materials for research and development, as borrower, in a $30 million credit facility extended by an international bank